Allscripts Appoints Vice President and Managing Director, EMEA

AllscriptsAllscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.

Strong said his first priorities for the coming year would be to increase the number of NHS trusts signed-up to deploy the Sunrise electronic patient record and to raise awareness of the capabilities of its dbMotion population health management solution.

He said he would also be looking to bring new clinical and departmental systems to the UK, while taking elements of the UK approach to the Middle East, where there is keen interest in population health management, as well as in administrative and clinical systems.

"Allscripts is well-established in the UK and popular with ourcustomers," he said. "I am looking forward to building onthe excellent work we have already achievedwithin the region with the Global Digital Exemplar programme in the UK and with customers that have benefited from our clinical wrap approach."

"I want more people to hear about what Allscripts has delivered at some of the top performing trusts in the United Kingdom, which use dbMotion to share information with GPs and explore population health management. As we develop our strategy for EMEA, I want more organisations to benefit from the solutions that we are already deploying across the UK."

Strong started his career in the NHS in London, where his work as a biomedical scientist drew him into the implementation of laboratory information systems. He went on to work for Siemens Healthcare Systems and then Cerner UK, where he played a key role in the implementation of electronic patient record systems in the capital, before becoming its director of European services.

He also worked in both UK and international roles for Dell, before joining Allscripts in 2016, to help grow its global ambitions.

Alan Fowles, President Allscripts International, said: "The creation of the new role of vice president and managing director, EMEA, shows our commitment to growing Allscripts as a global company."

"Richard's background in the health tech industry, and his deep understanding of the requirements of health and care organisations in the UK, across Europe, and in the Middle East makes him the ideal choice for the role, and we are confident that this will enable more organisations to benefit from Allscripts’ sector-leading solutions, knowledge and experience."

Allscripts' rapid expansion and high levels of customer satisfaction were recognised in a 2018 KLAS performance report on the European electronic record market, which noted that it had gone from one Sunrise customer in 2011 to eight when the report was written.

The company is currently running a clinical wrap campaign to support trusts that want to digitise without the cost and disruption caused by scrapping their existing patient administration systems and other IT investments.

This is in line with the NHS Long Term Plan’s recognition to complete the digitisation of hospitals through an extension of the GDE programme and an accelerated roll-out of EPRs. The plan also gave strong support to the development and deployment of population health management.

Some of the additional products that Allscripts will be bringing to the UK from other regions include Sunrise Surgical Care with iPro Anaesthesia, the Patient Flow with Census Logic hospital status application, and Follow My Health, a patient engagement platform, as well as integrated electronic document management.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...